CAREDX, INC. (CDNA) Return on equity 2016–2025
CAREDX, INC. (CDNA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-7.0%FY2025 · since FY2016: -202.6% → -7.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7.0% | -20.9 pp |
| FY2024 | 13.9% | +86.7 pp |
| FY2023 | -72.8% | -55.0 pp |
| FY2022 | -17.8% | -11.2 pp |
| FY2021 | -6.6% | +0.2 pp |
| FY2020 | -6.7% | +15.5 pp |
| FY2019 | -22.2% | +26.6 pp |
| FY2018 | -48.7% | — |
| FY2016 | -202.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CDNA financial trends
CDNA RevenueCDNA Net incomeCDNA Net marginCDNA Gross profitCDNA Gross marginCDNA Operating incomeCDNA Operating marginCDNA Operating cash flowCDNA Free cash flowCDNA Capital expendituresCDNA Stock buybacksCDNA Dividends paidCDNA Total assetsCDNA Total liabilitiesCDNA Shareholders’ equityCDNA overview →